Mutual of America Capital Management LLC Lowers Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Mutual of America Capital Management LLC decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.7% during the third quarter, according to its most recent filing with the SEC. The firm owned 12,652 shares of the biotechnology company’s stock after selling 481 shares during the period. Mutual of America Capital Management LLC’s holdings in Axon Enterprise were worth $5,056,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. 1832 Asset Management L.P. grew its stake in Axon Enterprise by 44.0% in the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after purchasing an additional 114,800 shares during the period. Allspring Global Investments Holdings LLC grew its position in shares of Axon Enterprise by 13.9% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock worth $108,496,000 after buying an additional 45,049 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of Axon Enterprise by 1.6% in the 2nd quarter. Thrivent Financial for Lutherans now owns 270,430 shares of the biotechnology company’s stock worth $79,571,000 after acquiring an additional 4,365 shares in the last quarter. Federated Hermes Inc. lifted its position in Axon Enterprise by 14.5% during the 2nd quarter. Federated Hermes Inc. now owns 234,185 shares of the biotechnology company’s stock valued at $68,907,000 after acquiring an additional 29,680 shares during the period. Finally, Hood River Capital Management LLC boosted its stake in Axon Enterprise by 5.2% during the second quarter. Hood River Capital Management LLC now owns 224,850 shares of the biotechnology company’s stock worth $66,160,000 after acquiring an additional 11,126 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on AXON. Barclays lifted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Craig Hallum increased their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Robert W. Baird lifted their price target on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Price Performance

Shares of AXON opened at $609.82 on Thursday. The firm has a fifty day simple moving average of $453.48 and a two-hundred day simple moving average of $363.68. The firm has a market cap of $46.50 billion, a PE ratio of 157.58, a P/E/G ratio of 15.05 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $224.28 and a 1-year high of $624.84.

Insider Activity at Axon Enterprise

In other news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at $1,121,052,771.48. This represents a 2.59 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 410,556 shares of company stock worth $161,192,754. 5.70% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.